PixCell Medical

Portable Medical Diagnostic Products for Point-of-care Testing

Health Tech & Life Sciences
Acquired by Soulbrain Holdings
Acquired Yokne'am Illit Founded 2008
Total raised
$7.5M
Last: Series B 2016-02
Stage
Acquired
Founded
2008
Headcount
68
HQ
Yokne'am Illit
Sector
Health Tech & Life Sciences

About

PixCell Medical offers a true point-of-care solution for complete blood count (CBC) tests, providing lab-quality precision with a small, simple diagnostic device. Within six minutes, PixCell's HemoScreen hematology analyzer provides fast and accurate analysis for the five-part differential CBC test with just a single drop of blood. The HemoScreen provides insights on 20 standard blood count parameters and comprehensive abnormal cell flagging, improving accessibility to CBC testing and reducing diagnostic turnaround time. The FDA-cleared and CE-marked HemoScreen has been fully validated in various clinical and academic settings worldwide and shown to produce lab-accurate results with comprehensive flagging of abnormal cells. PixCell's patented Viscoelastic Focusing technology and AI-powered machine-vision technology enable earlier detection of complex diseases (e.g., leukemia, lymphoma, and other cancers and infections), allowing faster diagnosis and treatment and setting the stage for improved patient outcomes.

Funding history · 3 rounds · $7.5M total

2016-02
Series B $1.0M
2013-10
Series A $2.0M
2011-04
Seed $1.5M

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics DevicesDigital HealthcareDigital Medical Diagnostics
Technologies
Artificial IntelligenceComputer Vision
Target customers
Healthcare & Life SciencesHealthcareProvidersPatients
Business model
B2B

Highlights

1 PatentsVerified

Tags

blood-testmedical-technologiesmedical-devicesdiagnosticshematologyhealthcare-providershospitalshome-careartificial-intelligenceoncologydigital-healthcarepatients